Following significant progress in its R&D pipeline, Sironax is embarking on a new phase of global expansion, focusing on the clinical development...
Developing innovative therapies for degenerative diseases presents scientific and clinical challenges at every stage – from early discovery to...
Sironax has recently completed its Phase I clinical trial for SIR2501, an innovative drug candidate with potential to treat neurodegenerative and...
Today marked a milestone moment for Sironax. We celebrated recent transformative achievements – the strategic expansion of our US team and IND...
Beijing, August 2, 2022 – Sironax, an emerging biotechnology company dedicated to the discovery and global development of novel treatments for...